The same SGLT2 inhibitor cardiologists prescribe as Jardiance — generic, FDA-approved, shipped monthly. In the EMPA-REG OUTCOME trial of 7,020 adults with type 2 diabetes and existing cardiovascular disease, empagliflozin cut cardiovascular death by 38% over 3.1 years (Zinman et al., NEJM 2015).
$1.5 per daily dose
Start My Eligibility Check (5 minutes, no charge until a doctor approves)A1c, eGFR, recent metabolic panel.
board-certified physician reviews your file, usually within 24 hours. If empagliflozin is wrong for you, they tell you and you pay nothing.
pharmacy and shipped to your door in discreet packaging. Refills auto-ship. Cancel from your dashboard.
average 2–3 kg over 24 weeks in pooled Phase 3 data
No injections. No titration schedule.
we order and review your eGFR and metabolic panel at intake and every 6 months.
EMPA-KIDNEY (NEJM 2023) — 6,609 adults with chronic kidney disease. 28% reduction in kidney disease progression or CV death. These results are for the specific trial populations above. They are not a
Normally, a protein called SGLT2 grabs that glucose and pulls it back into your blood. Empagliflozin blocks SGLT2. So instead of being recycled, the extra glucose leaves through your urine — about 60–80 grams a day, roughly 240–320 calories. Lower blood sugar, lower blood pressure, less fluid load on the heart. That's why it works in diabetes, in heart failure, and in kidney disease — even when blood sugar is already controlled.
Important information about Empagliflozin safety and side effects.
— It's FDA-approved generic empagliflozin, the same molecule as brand Jardiance, filled by a licensed U.S. pharmacy. Not compounded. Not imported. Not a research chemical.
— Empagliflozin is FDA-approved for type 2 diabetes, heart failure, and chronic kidney disease. Our physicians prescribe within those indications and your medical history. If you don't qualify, you don't get a prescription and you don't pay.
— Empagliflozin can cause diabetic ketoacidosis even at normal blood sugars, especially during fasting, surgery, or acute illness. Risk in non-diabetic adults is low but real. Our physicians screen for it and tell you the warning signs before you start.
— Roughly 5–6% of patients in trials had a yeast infection in the first few months, more often in women and uncircumcised men. Usually treated with one dose of antifungal. Drink water, stay clean, tell us if it happens.
— First-month money-back guarantee. If your labs don't move or you can't tolerate it, refund or switch — no questions.
— Long-term it protects them (see EMPA-KIDNEY). Short-term your eGFR can dip 3–5 points in the first month, then stabilize. We check before you start and won't prescribe below an eGFR of 20.
Real reviews from verified ArgoMD patients.
My A1c dropped significantly since starting Empagliflozin through ArgoMD. The regular lab monitoring gives me peace of mind and my doctor adjusts my dose based on real data.
Empagliflozin has been a cornerstone of my diabetes management. ArgoMD makes it easy — monthly delivery, physician oversight, and great customer service.
I was hesitant about telehealth but ArgoMD proved me wrong. My Empagliflozin prescription is managed expertly and my blood sugar control has never been better.
Your health and safety are our top priorities.